GL1X · GenesisL1 explorer

MolNFT v1 · #10958 · protein

Human high affinity Fc receptor FC(EPSILON)RI(ALPHA), hexagonal crystal form 1

1J87 · High affinity immunoglobulin epsilon receptor alpha- subunit: “Human high affinity Fc receptor FC(EPSILON)RI(ALPHA), hexagonal crystal form 1”. X-ray diffraction, 4 ligands (NAG, MAN, BMA), 2 pockets (best druggability 0.36). MolNFT…

PDB
1J87
Type
protein
Length
168 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
High affinity immunoglobulin epsilon receptor alpha- subunit
UniProt
P12319
Ligands
NAG, MAN, BMA, FUC
Pockets
2 · best druggability 0.36

Structure

x-ray diffraction · 1 distinct chain · 4% helix, 52% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AHigh affinity immunoglobulin epsilon receptor alpha- subunitprotein1684% helix, 52% strandP12319

Ligands and binding sites

  • NAG · 2-acetamido-2-deoxy-beta-D-glucopyranose · sugar · 8 copies · chains A
  • MAN · alpha-D-mannopyranose · sugar · 2 copies · chains A
  • BMA · beta-D-mannopyranose · sugar · chains A
  • FUC · alpha-L-fucopyranose · sugar

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

2 pockets found on a 1 Å grid, 0 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
11140.360.7316empty
2680.330.7614empty

Modifications

Observed in the structure: 4 glycan, 2 disulfide (N-glycosylation, disulfide).

Compared structures

  • 1J87 · Human high affinity Fc receptor FC(EPSILON)RI(ALPHA), hexagonal crystal form 1 · the same entry in another collection · chain A against A, TM-score 1.00
  • P12319 · AlphaFold monomer V2.0 prediction for high affinity immunoglobulin epsilon receptor… · a predicted model of the same protein · chain A against A, TM-score 0.94

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.